Skip to main content

Table 1 TRY, tryptophan; KYN, kynurenine; KYNA, kynurenic acid; QUIN, quinolinic acid; 5-HT, serotonin; Glu, glutamate; Gln, glutamine, LPS, lipopolysaccharide; HUCPVC, human umbilical cord perivascular cells; HS68, human foreskin fibroblast cells. Data represents mean (± SEM). n = 5–8 mice per group, (except HS68, n = 3). aSignificant effect of LPS (versus Control), bsignificant effect of HUCPVC (versus LPS), csignificant effect of HS68 (versus LPS), Ordinary One-way ANOVA with Tukey’s multiple comparison test. *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001

From: First trimester human umbilical cord perivascular cells (HUCPVC) modulate the kynurenine pathway and glutamate neurotransmission in an LPS-induced mouse model of neuroinflammation

Metabolite

Control

LPS

LPS + HUCPVC

LPS + HS68

Brain

    

TRY (nM)

172 (8.09)

209 (7.28)a*

170 (7.16)b*

236 (17.1)

KYN (nM)

12.8 (0.96)

61.1 (3.46)a****

43 (5.97)b*

47.9 (9.93)

KYN:TRY

0.077 (0.009)

0.338 (0.01)a****

0.238 (0.025)b*

0.173 (0.079)c**

KYNA (nM)

1.257 (0.155)

1.388 (0.060)

1.513 (0.237)

1.39 (0.206)

QUIN (nM)

3044 (604)

7892 (362)a***

4086 (651)b**

8090 (1311)

QUIN:KYNA

3081 (511)

5717 (330)a*

3080 (676)b*

5790 (229)

5-HT (nM)

385 (40.9)

520 (50.6)

464 (42.6)

507 (3.33)

Glu (µM)

909 (66)

893 (36)

893 (43)

1103 (281)

Gln (µM)

1853 (179.5)

2025 (162.1)

2012 (138.4)

2374 (583)

Plasma

    

TRY (µM)

0.758 (0.030)

0.756 (0.033)

0.741 (0.046)

0.746 (0.103)

KYN (µM)

0.824 (0.061)

1.155 (0.168)

1.155 (0.133)

0.915 (0.040)

KYN:TRY

1.106 (0.103)

1.71 (0.212)a*

1.54 (0.104)

1.28 (0.208)

KYNA (µM)

0.159 (0.005)

0.14 (0.014)

0.141 (0.010)

0.151 (0.003)

QUIN (µM)

4.389 (0.392)

4.751 (0.507)

3.808 (0.465)

4.403 (0.336)

QUIN:KYNA

27.9 (3.16)

44.3 (17.7)

30.1 (4.38)

29.2 (2.75)

5-HT (µM)

3.19 (0.411)

3.24 (0.525)

3.12 (0.494)

2.47 (0.070)

Glu (µM)

11.1 (1.82)

12 (2.19)

9.31 (1.88)

10.1 (3.12)

Gln (µM)

170.1 (26.6)

169.5 (24.4)

135.1 (18.1)

176.5 (20.5)

Assessment of Kynurenine pathway metabolites, serotonin, glutamate and glutamine levels by LC-MS after 24 h LPS treatment along with either HUCPVCs or HS68